Evaluation of a Yoga-Based Cancer Rehabilitation Program
18 Years
N/A
Both
Breast Neoplasms, Colorectal Neoplasms, Lung Neoplasms
Trial Information
Evaluation of a Yoga-Based Cancer Rehabilitation Program
Research on yoga is extensive in both healthy and chronically ill individuals including
cardiovascular disease, chronic pain, diabetes, asthma, headache, anxiety and depression.
Benefits of yoga include: improved mood, energy, memory, concentration, flexibility,
physical fitness, breathing capacity, and decreased pain, blood pressure, and cholesterol.
There is paucity of controlled research studies on the effects of yoga for cancer patients.
Yoga is an ideal intervention to improve quality of life for patients with cancer because it
incorporates elements of relaxation, social support, and exercise, all found to improve
quality of life. This randomized-controlled study compares a 12-week yoga intervention to
standard care on quality of life among patients with early-stage breast, lung, and
colorectal cancer. Quality of life assessments are conducted at baseline, and at one,
three, and six month intervals.
Inclusion Criteria:
- Diagnosis of Breast Cancer (Stages I, II, or III), Colorectal Cancer (Stages I, II,
or III), or Lung Cancer (Stages I, II)
- Diagnosed with new or recurrent cancer within past 5 years
- Language is English or Spanish
- Recovered from surgery and any postoperative complications requiring hospitalization
Exclusion Criteria:
- Current Yoga Practice >1x month
- Unable to attend yoga class due to time conflict
- Advanced cancer with symptomatic pulmonary, skeletal or brain metastases
- Second Primary cancer that is active
- ECOG performance status of 3 or 4
- Seizures
- Arthritis or muscle pain, if severe enough to interfere with simple Yogic exercises
- Asthma or difficulty breathing, if severe enough to interfere with ability to perform
deep breathing
- Uncontrolled hypertension
- Heart condition or problems
- Current (Uncontrolled) major psychiatric disorder
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Supportive Care
Outcome Measure:
Functional Assessment of Cancer Therapy
Outcome Time Frame:
Baseline to 3 months and 6 months
Safety Issue:
No
Principal Investigator
Alyson Moadel, Ph.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Albert Einstein College of Medicine of Yeshiva University
Authority:
United States: Institutional Review Board
Study ID:
#2000-007
NCT ID:
NCT00179348
Start Date:
April 2001
Completion Date:
March 2012
Related Keywords:
- Breast Neoplasms
- Colorectal Neoplasms
- Lung Neoplasms
- Yoga
- Breast Neoplasms
- Colorectal Neoplasms
- Lung Neoplasms
- Breast Neoplasms
- Neoplasms
- Colorectal Neoplasms
- Lung Neoplasms
Name | Location |
|---|---|
| Albert Einstein College of Medicine | Bronx, New York 10461 |
